Catalyst Wire Dossier Catalyst Wire Dossier

Xeruborbactam oral prodrug

Xeruborbactam · Qpex Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xeruborbactam oral prodrug, covering 2025-05-14 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants [Phase 1]

See pricing